Can A Safety Study Support A Superiority Claim? Barely, US FDA Advisors Say

Using a clinical trial originally designed for safety to support an efficacy superiority claim poses unique challenges that can make reliance upon a single study for regulatory purposes potentially risky.

Using a clinical trial originally designed for safety to support an efficacy superiority claim poses unique challenges that can make reliance upon a single study for regulatory purposes potentially risky.

That was one take-home message from the US Food and Drug Administration's Endocrinologic and Metabolic Drugs Advisory Committee's June 28...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet